Showing results (531-540 of 796) with videos related to
Sort By:
Pageof 80
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|April 14, 2017
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version)Christoph F Dietrich, Jeffrey Bamber, Annalisa Berzigotti, et al.Diabetes|March 5, 2013
Mechanisms underlying the onset of oral lipid-induced skeletal muscle insulin resistance in humansBettina Nowotny, Lejla Zahiragic, Dorothea Krog, et al.The Journal of Clinical Endocrinology and Metabolism|February 2, 2016
Specific Metabolic Profiles and Their Relationship to Insulin Resistance in Recent-Onset Type 1 and Type 2 DiabetesBirgit Knebel, Klaus Strassburger, Julia Szendroedi, et al.BMJ Open|February 4, 2022
BOND study: a randomised double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological and clinical measures in patients with type 2 diabetes with symptomatic polyneuropathyGidon J Bönhof, Gundega Sipola, Alexander Strom, et al.Acta Radiologica (Stockholm, Sweden : 1987)|January 9, 2023
Validation of a screening algorithm for hepatic fibrosis by Doppler ultrasound and elastography in a general populationAnne-Sophie Renard, Anita Paisant, Victoire Cartier, et al.Journal of Hepatology|December 11, 2020
Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver diseaseMargarita Papatheodoridi, Jean Baptiste Hiriart, Monica Lupsor-Platon, et al.Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|April 14, 2017
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Short Version)Christoph F Dietrich, Jeffrey Bamber, Annalisa Berzigotti, et al.Diabetes Care|April 12, 2023
High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low ThresholdLaurent Castera, Cédric Laouenan, Anaïs Vallet-Pichard, et al.American Journal of Physiology. Endocrinology and Metabolism|August 19, 2007
A Thr94Ala mutation in human liver fatty acid-binding protein contributes to reduced hepatic glycogenolysis and blunted elevation of plasma glucose levels in lipid-exposed subjectsMartin O Weickert, Christian V Loeffelholz, Michael Roden, et al.European Journal of Clinical Investigation|July 9, 2025
Higher afamin concentrations are associated with higher fatty liver indices: Population-based KORA F4/FF4 studyCorinna Niersmann, Anna Zhu, Haifa Maalmi, et al.Pageof 80